- تیر ۱, ۱۴۰۱
- نویسنده:
- دسته بندی: دستهبندی نشده
Item 5.07 Submission of Matters to a Vote of Security Holders. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today . You are about to review presentations, reports and/or filings of AIkido Pharma Inc., that contain time-sensitive information. * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. * Aikido Pharma Inc - REVERSE STOCK SPLIT WILL BECOME EFFECTIVE AT 12:01 A.M. EASTERN TIME ON JUNE 7, 2022 Source text for Eikon: Further company coverage: The information contained therein is only accurate as of the . AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of . Announces $22 Million Registered Direct Offering. Proposed Reverse Stock Split. . Prices shown are actual historical values and are not adjusted for either splits or dividends. AIKIDO PHARMA : News, Nachrichten und Informationen Aktie AIKIDO PHARMA | A2P1UN | US0088751062 | Nasdaq Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Village Farms International Named to Corporate Knights' Inaugural Future 50: The . Anthony Hayes, CEO of AIkido, stated, "The . Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Glass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharma Inc. * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy Statement for . NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy . NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today . AIkido Announces Reverse Stock Split: PR. View analysts' price targets for AIkido Pharma or view top-rated stocks among Wall Street analysts. AIKIDO PHARMA : News, information and stories for AIKIDO PHARMA | Nasdaq: AIKI | Nasdaq. Start your FREE 14-day trial of Benzinga Pro today. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy . 05/16: Tranche Update on AIkido Pharma Inc.'s Equity Buyback Plan announced on January 24, 202.. CI. NEW YORK, Nov. 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (the "Company" or "AIkido") (NASDAQ: . NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Dear Mr. Jaegers; Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: FOR the amendment to effect reverse stock split ; Proposals 2, 3a,3b,3c,3d, 3e, 3f, 4, 5, and 6 will be voted FOR in order to complete the proxy. Importantly,. MT Newswires. GuruFocus Article or News written by PRNewswire and the topic is about: AIkido Pharma Shares Resume Trading, Continue Higher. NEW YORK, April 22, 2022-- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy . . On January 12, 2021, AIkido Pharma Inc., a Delaware corporation , reconvened its 2020 annual meeting of stockholders . At the Meeting,. 06/03 16:41. The Board's primary objective in proposing a potential reverse split is to raise the per share trading price of our common stock to allow the Company to regain compliance with the Nasdaq minimum . * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. You will never again be left in the dark on when a stock moves. AIkido Pharma Approves 1-for-17 Reverse Split of Common Stock. The Board's primary objective in proposing a potential reverse split is to raise the per share trading price of our common stock to allow the Company to regain compliance with the Nasdaq minimum . Stock Market News for Traders and Investors | June 4, 2022 SPX 4,108.54 -68.28 -1.63 %. Proposed Reverse Stock Split Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper . new york, april 22, 2022 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today reported that, on april 20, 2022, the independent proxy paper analysis firm glass lewis. With respect to Proposal (4) in the Proxy Statement to effect a reverse split of the Company's common stock, the GL Report recommends "FOR" the proposal. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ: AIKI ), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). | June 4, 2022 The move is aligned to increase the market price per share of the company's. AIkido Pharma Inc. is focused on the treatment of four cancers, prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). * Aikido Pharma . VFF. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today . BETA. Re: AIkido Pharma Inc. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). Alkido Pharma ( NASDAQ: AIKI) stated Friday it has received Board's approval to execute a 1-for-17 reverse stock split. Includes date and ratio. Yes, the most recent reverse stock splits occurred in September 2008, November 2008, May 2011 & September 2012. AIKIDO PHARMA : Noticias, novedades e informacin accin AIKIDO PHARMA | AIKI | US0088751062 | Nasdaq Glass Lewis Proxy Paper Report Recommends 'FOR' AIkido Pharma Proposed Reverse Stock Split. The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on June 7, 2022 and the Company's common stock will open for trading on The . . Please see the "Historical Prices" tab for adjusted price values. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. AIKI ("AIkido" or the "Company") today reported that, on . Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company NEW YORK , April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that. On average, they expect AIkido Pharma's share price to reach $2.00 in the next twelve months. 05/19: AIkido Pharma Announces Company Commitment to Board Diversity: PR. * Aikido Pharma Inc - BOARD OF DIRECTORS HAS APPROVED A REVERSE STOCK SPLIT OF ITS SHARES OF COMMON STOCK AT A RATIO OF 1 FOR 17. Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. AIKIDO PHARMA: attualit, news e informazioni azione AIKIDO PHARMA | AIKI | US0088751062 | Nasdaq The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on June 7, 2022 and the Company's common stock will open for trading on The . AIKIDO PHARMA : Bedrijfscommunicatie en persberichten AIKIDO PHARMA | AIKI | US0088751062 | Nasdaq The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on June 7, 2022 and the Company's common stock will open for trading on The . Importantly,. The Series O and Series P preferred stock and shares of common stock into which such preferred stock are convertible were offered pursuant to a registration statement on Form S-3 (333-238172 . April 22, 2022 - 10:00 am. Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. * Aikido Pharma . Anthony Hayes, CEO of AIkido, stated, "The Company's Board of Directors strongly believes that the proposed reverse split is in the best interest of the Company and the stockholders. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy Statement for . Stock Titan. NEW YORK, Nov. 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. today announced the results from the virtual 2020 Annual Meeting of Stockholders held on November 17, 2020 . Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at . AIkido Announces Reverse Stock Split. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy Statement for . 03/06 AIkido Pharma Approves 1-for-17 Reverse Split of Common Stock 03/06 AIkido Announces Reverse Stock Split 25/05 AIKIDO PHARMA INC.: Submission of Matters to a Vote of Security Holders (form 8 . Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). You'll have what you need to act in real-time before the crowd. AIkido Pharma Inc. AIKIDO PHARMA : News, Nachrichten und Informationen Aktie AIKIDO PHARMA | AIKI | US0088751062 | Nasdaq Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Aikido Pharma Inc (AIKI): * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on June 7, 2022 and the Company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis on. NEW YORK, NY February 25, 2022 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase 11,000 shares of Series O redeemable convertible preferred stock and 11,000 shares of Series P . | June 4, 2022 Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy Statement for . See AIkido Pharma Inc. (AIKI) history of stock splits. When Was The Company Founded? With respect to Proposal (4) in the Proxy Statement to effect a reverse split of the Company's common stock, the GL Report recommends "FOR" the proposal. Glass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharma Inc. AIkido Pharma also has an Exclusive World-Wide License to Broad Spectrum Antiviral Drug Platform, Includes Coronavirus, from the University of Maryland Baltimore. AIkido Announces Reverse Stock Split PR Newswire NEW YORK, June 3, 2022 NEW YORK , June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today Aikido Pharma Inc (): * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. Anthony Hayes, CEO of AIkido, stated, "The Company's Board of Directors strongly believes that the proposed reverse split is in the best interest of the Company and the stockholders. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today . Compare AIKI With Other Stocks 2-1 0.1-1 0.1-1 0.1-1 0.2-1 1985 1990 1995 2000 2005 2010 2015 2020 2 4 6 8 10 12 14 Any fractional share resulting from the Reverse Stock Split would be rounded down to the nearest whole share, and any stockholder who . Anthony Hayes, CEO of AIkido, stated, "The Company's Board of Directors strongly believes that the proposed reverse split is in the best interest of the Company and the stockholders. AIKIDO PHARMA : Nieuws en informatie aandeel AIKIDO PHARMA | AIKI | Nasdaq 41 minutes ago NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). Aikido Pharma Inc (AIKI): * AIKIDO ANNOUNCES REVERSE STOCK SPLIT. You are cordially invited to attend AIkido Pharma Inc.'s 2022 Annual Meeting of Stockholders (the "Annual Meeting") to be held on Monday, May 16, 2022, at 9:00 a.m. Pacific Time/12:00 p.m. Eastern Time. AIkido Announces Reverse Stock Split NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock Approval of the Amendment Proposal and the resulting reverse stock split is critical. Stock. In depth view into AIKI (AIkido Pharma) stock including the latest price, news, dividend history, earnings information and financials. AIkido Pharma Approves 1-for-17 Reverse Split of Common Stock. Anthony Hayes, CEO of AIkido, stated, "The Company's Board of Directors strongly believes that the proposed reverse split is in the best interest of the Company and the stockholders. . 761 members in the StockTitan community. With respect to Proposal (4) in the Proxy Statement to effect a reverse split of the Company's common stock, the GL Report recommends "FOR" the proposal. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a. This suggests a possible upside of 562.3% from the stock's current price. AIkido Announces Reverse Stock Split; Trending News. Annual Meeting . NEW YORK, March 2, 2022 /PRNewswire/ -- AIkido Pharma Inc. , today announced the closing of its previously announced registered direct offering with certain institutional investors of 11,000. Shares of AIkido Pharma Inc. fell in after-hours trading after the company said its board of directors has approved a reverse stock split at a ratio of 1 for 17 in an effort to gain listing. Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. Stock Splits Market Cap Stock split history for AIkido Pharma since 1984. NEW YORK, April 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an analysis of the proposals contained in the Company's "Proxy Statement for . The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on June NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). May 1992. . Analysis Firm Agrees that Reverse Split Is in the Best Interest of the Company. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 17 (the "Reverse Stock Split"). Benzinga - Apr 22, 2022, 10:02AM. . PR Newswire. NEW YORK, June 3, 2022 /PRNewswire/ -- AIkido Pharma, Inc. (NASDAQ:AIKI), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a. Reference is made to those certain Common Stock Purchase Warrants (the "Warrants") of the Company issued to each Warrant Holder (as designated assignees of H.C. W AIKI Securities Purchase Agreement bt and between Convergent Therapeutics, Inc. and AIkido Pharma Inc., dated January 29, 2021 (incorporated by reference to Form 8-K filed . Their forecasts range from $2.00 to $2.00.